Department of Biomedical Engineering, Zhejiang University, Hangzhou, P. R. China.
Biol Pharm Bull. 2009 Sep;32(9):1545-51. doi: 10.1248/bpb.32.1545.
B-type natriuretic peptide (BNP) is one peptide hormone released in response to myocyte stretch, whose functions play significant roles in health and disease. Its physiologic effects result in improved loading conditions and have led to the development of recombinant BNP as a therapeutic agent for heart failure. Previous work has identified that BNP protect myocardium against reperfusion injury through mitochondrial pathway. Mitochondria are both essential effectors of cardioprotection and primary targets of cardioprotective signaling. Their role during reperfusion is particularly critical because of the conditions that promote both apoptosis by the mitochondrial pathway and necrosis by irreversible damage to mitochondria in association with mitochondrial permeability transition pores (mPTP). After an episode of myocardial ischemia, opening of mPTP, at the onset of reperfusion, is a critical determinant of myocyte death. The relationship of BNP and mPTP in mediating reperfusion-induced cardiomyocytes injury is a novel investigative area. In this study, our results indicated that the beneficial effect of BNP in cultured cardiomyocytes subjected to reperfusion is associated with attenuation of mPTP opening, resultant mitochondrial dysfunction and apoptosis. Further investigation of underlying mechanisms revealed that these were associated with BNP-mediated repolarization of mitochondrial membrane potential (Deltapsi(m)), inhibition of reactive oxygen species (ROS) generation, improvement of Bcl-2 level, and inhibition of Bax and second mitochondria-derived activator of caspases/direct inhibitor of apoptosis protein-binding protein with a low isoelectric point (Smac/DIABLO) levels. In summary, we demonstrate that BNP exerts protective actions within reperfusion by inhibiting mPTP opening and these roles of BNP may involve phosphatidylinositol 3-kinase (PI3K) dependent pathway.
B 型利钠肽(BNP)是一种对心肌细胞拉伸作出反应而释放的肽类激素,其功能在健康和疾病中发挥着重要作用。它的生理作用导致了负荷条件的改善,并导致了重组 BNP 的开发,作为心力衰竭的治疗剂。以前的工作已经确定 BNP 通过线粒体途径保护心肌免受再灌注损伤。线粒体既是心脏保护的基本效应器,也是心脏保护信号的主要靶标。它们在再灌注期间的作用特别关键,因为再灌注条件既可以通过线粒体途径促进细胞凋亡,也可以通过与线粒体通透性转换孔(mPTP)相关的线粒体不可逆损伤导致细胞坏死。在心肌缺血发作后,mPTP 的开放是再灌注期间心肌细胞死亡的关键决定因素。BNP 与 mPTP 在介导再灌注诱导的心肌细胞损伤中的关系是一个新的研究领域。在这项研究中,我们的结果表明,BNP 对再灌注培养的心肌细胞的有益作用与 mPTP 开放的减弱、线粒体功能障碍和细胞凋亡有关。进一步的机制研究表明,这与 BNP 介导的线粒体膜电位(Deltapsi(m))复极化、抑制活性氧(ROS)生成、提高 Bcl-2 水平以及抑制 Bax 和第二线粒体衍生的半胱天冬酶激活剂/凋亡抑制剂结合蛋白低等有关。总之,我们证明 BNP 通过抑制 mPTP 开放在再灌注中发挥保护作用,BNP 的这些作用可能涉及磷脂酰肌醇 3-激酶(PI3K)依赖性途径。